Copyright Reports & Markets. All rights reserved.

Global Pet Biopharmaceuticals Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Pet Biopharmaceuticals Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Antiparasitic
    • 1.2.3 Biological Products
    • 1.2.4 Antibacterial
    • 1.2.5 Others
  • 1.3 Market by Application
    • 1.3.1 Global Pet Biopharmaceuticals Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Prevention
    • 1.3.3 Treatment
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Pet Biopharmaceuticals Market Perspective (2016-2027)
  • 2.2 Pet Biopharmaceuticals Growth Trends by Regions
    • 2.2.1 Pet Biopharmaceuticals Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Pet Biopharmaceuticals Historic Market Share by Regions (2016-2021)
    • 2.2.3 Pet Biopharmaceuticals Forecasted Market Size by Regions (2022-2027)
  • 2.3 Pet Biopharmaceuticals Industry Dynamic
    • 2.3.1 Pet Biopharmaceuticals Market Trends
    • 2.3.2 Pet Biopharmaceuticals Market Drivers
    • 2.3.3 Pet Biopharmaceuticals Market Challenges
    • 2.3.4 Pet Biopharmaceuticals Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Pet Biopharmaceuticals Players by Revenue
    • 3.1.1 Global Top Pet Biopharmaceuticals Players by Revenue (2016-2021)
    • 3.1.2 Global Pet Biopharmaceuticals Revenue Market Share by Players (2016-2021)
  • 3.2 Global Pet Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Pet Biopharmaceuticals Revenue
  • 3.4 Global Pet Biopharmaceuticals Market Concentration Ratio
    • 3.4.1 Global Pet Biopharmaceuticals Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Pet Biopharmaceuticals Revenue in 2020
  • 3.5 Pet Biopharmaceuticals Key Players Head office and Area Served
  • 3.6 Key Players Pet Biopharmaceuticals Product Solution and Service
  • 3.7 Date of Enter into Pet Biopharmaceuticals Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Pet Biopharmaceuticals Breakdown Data by Type

  • 4.1 Global Pet Biopharmaceuticals Historic Market Size by Type (2016-2021)
  • 4.2 Global Pet Biopharmaceuticals Forecasted Market Size by Type (2022-2027)

5 Pet Biopharmaceuticals Breakdown Data by Application

  • 5.1 Global Pet Biopharmaceuticals Historic Market Size by Application (2016-2021)
  • 5.2 Global Pet Biopharmaceuticals Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Pet Biopharmaceuticals Market Size (2016-2027)
  • 6.2 North America Pet Biopharmaceuticals Market Size by Type
    • 6.2.1 North America Pet Biopharmaceuticals Market Size by Type (2016-2021)
    • 6.2.2 North America Pet Biopharmaceuticals Market Size by Type (2022-2027)
    • 6.2.3 North America Pet Biopharmaceuticals Market Size by Type (2016-2027)
  • 6.3 North America Pet Biopharmaceuticals Market Size by Application
    • 6.3.1 North America Pet Biopharmaceuticals Market Size by Application (2016-2021)
    • 6.3.2 North America Pet Biopharmaceuticals Market Size by Application (2022-2027)
    • 6.3.3 North America Pet Biopharmaceuticals Market Size by Application (2016-2027)
  • 6.4 North America Pet Biopharmaceuticals Market Size by Country
    • 6.4.1 North America Pet Biopharmaceuticals Market Size by Country (2016-2021)
    • 6.4.2 North America Pet Biopharmaceuticals Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Pet Biopharmaceuticals Market Size (2016-2027)
  • 7.2 Europe Pet Biopharmaceuticals Market Size by Type
    • 7.2.1 Europe Pet Biopharmaceuticals Market Size by Type (2016-2021)
    • 7.2.2 Europe Pet Biopharmaceuticals Market Size by Type (2022-2027)
    • 7.2.3 Europe Pet Biopharmaceuticals Market Size by Type (2016-2027)
  • 7.3 Europe Pet Biopharmaceuticals Market Size by Application
    • 7.3.1 Europe Pet Biopharmaceuticals Market Size by Application (2016-2021)
    • 7.3.2 Europe Pet Biopharmaceuticals Market Size by Application (2022-2027)
    • 7.3.3 Europe Pet Biopharmaceuticals Market Size by Application (2016-2027)
  • 7.4 Europe Pet Biopharmaceuticals Market Size by Country
    • 7.4.1 Europe Pet Biopharmaceuticals Market Size by Country (2016-2021)
    • 7.4.2 Europe Pet Biopharmaceuticals Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Pet Biopharmaceuticals Market Size (2016-2027)
  • 8.2 Asia-Pacific Pet Biopharmaceuticals Market Size by Type
    • 8.2.1 Asia-Pacific Pet Biopharmaceuticals Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Pet Biopharmaceuticals Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Pet Biopharmaceuticals Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Pet Biopharmaceuticals Market Size by Application
    • 8.3.1 Asia-Pacific Pet Biopharmaceuticals Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Pet Biopharmaceuticals Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Pet Biopharmaceuticals Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Pet Biopharmaceuticals Market Size by Region
    • 8.4.1 Asia-Pacific Pet Biopharmaceuticals Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Pet Biopharmaceuticals Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Pet Biopharmaceuticals Market Size (2016-2027)
  • 9.2 Latin America Pet Biopharmaceuticals Market Size by Type
    • 9.2.1 Latin America Pet Biopharmaceuticals Market Size by Type (2016-2021)
    • 9.2.2 Latin America Pet Biopharmaceuticals Market Size by Type (2022-2027)
    • 9.2.3 Latin America Pet Biopharmaceuticals Market Size by Type (2016-2027)
  • 9.3 Latin America Pet Biopharmaceuticals Market Size by Application
    • 9.3.1 Latin America Pet Biopharmaceuticals Market Size by Application (2016-2021)
    • 9.3.2 Latin America Pet Biopharmaceuticals Market Size by Application (2022-2027)
    • 9.3.3 Latin America Pet Biopharmaceuticals Market Size by Application (2016-2027)
  • 9.4 Latin America Pet Biopharmaceuticals Market Size by Country
    • 9.4.1 Latin America Pet Biopharmaceuticals Market Size by Country (2016-2021)
    • 9.4.2 Latin America Pet Biopharmaceuticals Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Pet Biopharmaceuticals Market Size (2016-2027)
  • 10.2 Middle East & Africa Pet Biopharmaceuticals Market Size by Type
    • 10.2.1 Middle East & Africa Pet Biopharmaceuticals Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Pet Biopharmaceuticals Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Pet Biopharmaceuticals Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Pet Biopharmaceuticals Market Size by Application
    • 10.3.1 Middle East & Africa Pet Biopharmaceuticals Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Pet Biopharmaceuticals Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Pet Biopharmaceuticals Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Pet Biopharmaceuticals Market Size by Country
    • 10.4.1 Middle East & Africa Pet Biopharmaceuticals Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Pet Biopharmaceuticals Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Zoetis
    • 11.1.1 Zoetis Company Details
    • 11.1.2 Zoetis Business Overview
    • 11.1.3 Zoetis Pet Biopharmaceuticals Introduction
    • 11.1.4 Zoetis Revenue in Pet Biopharmaceuticals Business (2016-2021)
    • 11.1.5 Zoetis Recent Development
  • 11.2 Boehringer Ingelheim
    • 11.2.1 Boehringer Ingelheim Company Details
    • 11.2.2 Boehringer Ingelheim Business Overview
    • 11.2.3 Boehringer Ingelheim Pet Biopharmaceuticals Introduction
    • 11.2.4 Boehringer Ingelheim Revenue in Pet Biopharmaceuticals Business (2016-2021)
    • 11.2.5 Boehringer Ingelheim Recent Development
  • 11.3 Merck
    • 11.3.1 Merck Company Details
    • 11.3.2 Merck Business Overview
    • 11.3.3 Merck Pet Biopharmaceuticals Introduction
    • 11.3.4 Merck Revenue in Pet Biopharmaceuticals Business (2016-2021)
    • 11.3.5 Merck Recent Development
  • 11.4 Elanco
    • 11.4.1 Elanco Company Details
    • 11.4.2 Elanco Business Overview
    • 11.4.3 Elanco Pet Biopharmaceuticals Introduction
    • 11.4.4 Elanco Revenue in Pet Biopharmaceuticals Business (2016-2021)
    • 11.4.5 Elanco Recent Development
  • 11.5 Virbac
    • 11.5.1 Virbac Company Details
    • 11.5.2 Virbac Business Overview
    • 11.5.3 Virbac Pet Biopharmaceuticals Introduction
    • 11.5.4 Virbac Revenue in Pet Biopharmaceuticals Business (2016-2021)
    • 11.5.5 Virbac Recent Development
  • 11.6 Dechra Veterinary Products
    • 11.6.1 Dechra Veterinary Products Company Details
    • 11.6.2 Dechra Veterinary Products Business Overview
    • 11.6.3 Dechra Veterinary Products Pet Biopharmaceuticals Introduction
    • 11.6.4 Dechra Veterinary Products Revenue in Pet Biopharmaceuticals Business (2016-2021)
    • 11.6.5 Dechra Veterinary Products Recent Development
  • 11.7 Ceva
    • 11.7.1 Ceva Company Details
    • 11.7.2 Ceva Business Overview
    • 11.7.3 Ceva Pet Biopharmaceuticals Introduction
    • 11.7.4 Ceva Revenue in Pet Biopharmaceuticals Business (2016-2021)
    • 11.7.5 Ceva Recent Development
  • 11.8 Vetoquinol
    • 11.8.1 Vetoquinol Company Details
    • 11.8.2 Vetoquinol Business Overview
    • 11.8.3 Vetoquinol Pet Biopharmaceuticals Introduction
    • 11.8.4 Vetoquinol Revenue in Pet Biopharmaceuticals Business (2016-2021)
    • 11.8.5 Vetoquinol Recent Development
  • 11.9 Ouro Fino Saude
    • 11.9.1 Ouro Fino Saude Company Details
    • 11.9.2 Ouro Fino Saude Business Overview
    • 11.9.3 Ouro Fino Saude Pet Biopharmaceuticals Introduction
    • 11.9.4 Ouro Fino Saude Revenue in Pet Biopharmaceuticals Business (2016-2021)
    • 11.9.5 Ouro Fino Saude Recent Development
  • 11.10 Norbrook
    • 11.10.1 Norbrook Company Details
    • 11.10.2 Norbrook Business Overview
    • 11.10.3 Norbrook Pet Biopharmaceuticals Introduction
    • 11.10.4 Norbrook Revenue in Pet Biopharmaceuticals Business (2016-2021)
    • 11.10.5 Norbrook Recent Development
  • 11.11 Jindun
    • 11.11.1 Jindun Company Details
    • 11.11.2 Jindun Business Overview
    • 11.11.3 Jindun Pet Biopharmaceuticals Introduction
    • 11.11.4 Jindun Revenue in Pet Biopharmaceuticals Business (2016-2021)
    • 11.11.5 Jindun Recent Development
  • 11.12 Chopperlvya Animal Health
    • 11.12.1 Chopperlvya Animal Health Company Details
    • 11.12.2 Chopperlvya Animal Health Business Overview
    • 11.12.3 Chopperlvya Animal Health Pet Biopharmaceuticals Introduction
    • 11.12.4 Chopperlvya Animal Health Revenue in Pet Biopharmaceuticals Business (2016-2021)
    • 11.12.5 Chopperlvya Animal Health Recent Development
  • 11.13 CAHIC
    • 11.13.1 CAHIC Company Details
    • 11.13.2 CAHIC Business Overview
    • 11.13.3 CAHIC Pet Biopharmaceuticals Introduction
    • 11.13.4 CAHIC Revenue in Pet Biopharmaceuticals Business (2016-2021)
    • 11.13.5 CAHIC Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Pet Biopharmaceuticals Scope and Market Size
    Pet Biopharmaceuticals market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pet Biopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Antiparasitic
    Biological Products
    Antibacterial
    Others

    Segment by Application
    Prevention
    Treatment

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Zoetis
    Boehringer Ingelheim
    Merck
    Elanco
    Virbac
    Dechra Veterinary Products
    Ceva
    Vetoquinol
    Ouro Fino Saude
    Norbrook
    Jindun
    Chopperlvya Animal Health
    CAHIC

    Buy now